Novartis terminates plant contract with Chinese CDMO Porton, threatens $64M in legal claims

A Novartis cross-border partnership is turning into a standoff. | A Novartis cross-border partnership is turning into a standoff. The Swiss pharma has unilaterally terminated a plant leasing contract with Chinese CDMO Porton Pharma Solutions after a regulatory hiccup.